445 related articles for article (PubMed ID: 12447390)
41. High NaCl causes Mre11 to leave the nucleus, disrupting DNA damage signaling and repair.
Dmitrieva NI; Bulavin DV; Burg MB
Am J Physiol Renal Physiol; 2003 Aug; 285(2):F266-74. PubMed ID: 12684226
[TBL] [Abstract][Full Text] [Related]
42. A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response.
Zhang D; Zaugg K; Mak TW; Elledge SJ
Cell; 2006 Aug; 126(3):529-42. PubMed ID: 16901786
[TBL] [Abstract][Full Text] [Related]
43. Alteration/deficiency in activation-3 (Ada3) plays a critical role in maintaining genomic stability.
Mirza S; Katafiasz BJ; Kumar R; Wang J; Mohibi S; Jain S; Gurumurthy CB; Pandita TK; Dave BJ; Band H; Band V
Cell Cycle; 2012 Nov; 11(22):4266-74. PubMed ID: 23095635
[TBL] [Abstract][Full Text] [Related]
44. [ATM/ATR signaling pathway activation in human embryonic stem cells after DNA damage].
Suvorova II; Kozhukharova IV; Nikol'skiĭ NN; Pospelov VA
Tsitologiia; 2013; 55(12):841-51. PubMed ID: 25474902
[TBL] [Abstract][Full Text] [Related]
45. 53BP1 exchanges slowly at the sites of DNA damage and appears to require RNA for its association with chromatin.
Pryde F; Khalili S; Robertson K; Selfridge J; Ritchie AM; Melton DW; Jullien D; Adachi Y
J Cell Sci; 2005 May; 118(Pt 9):2043-55. PubMed ID: 15840649
[TBL] [Abstract][Full Text] [Related]
46. Kinetics of histone H2AX phosphorylation and Chk2 activation in A549 cells treated with topotecan and mitoxantrone in relation to the cell cycle phase.
Zhao H; Traganos F; Darzynkiewicz Z
Cytometry A; 2008 Jun; 73(6):480-9. PubMed ID: 18459160
[TBL] [Abstract][Full Text] [Related]
47. Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells.
Yu Q; Rose JH; Zhang H; Pommier Y
FEBS Lett; 2001 Sep; 505(1):7-12. PubMed ID: 11557032
[TBL] [Abstract][Full Text] [Related]
48. Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.
Rasche L; Heiserich L; Behrens JR; Lenz K; Pfuhl C; Wakonig K; Gieß RM; Freitag E; Eberle C; Wuerfel J; Dörr J; Bauer P; Bellmann-Strobl J; Paul F; Roggenbuck D; Ruprecht K
PLoS One; 2016; 11(1):e0147968. PubMed ID: 26820970
[TBL] [Abstract][Full Text] [Related]
49. Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest.
Sengupta S; Robles AI; Linke SP; Sinogeeva NI; Zhang R; Pedeux R; Ward IM; Celeste A; Nussenzweig A; Chen J; Halazonetis TD; Harris CC
J Cell Biol; 2004 Sep; 166(6):801-13. PubMed ID: 15364958
[TBL] [Abstract][Full Text] [Related]
50. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.
Morales JC; Franco S; Murphy MM; Bassing CH; Mills KD; Adams MM; Walsh NC; Manis JP; Rassidakis GZ; Alt FW; Carpenter PB
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3310-5. PubMed ID: 16492765
[TBL] [Abstract][Full Text] [Related]
51. Negative cell cycle regulation and DNA damage-inducible phosphorylation of the BRCT protein 53BP1.
Xia Z; Morales JC; Dunphy WG; Carpenter PB
J Biol Chem; 2001 Jan; 276(4):2708-18. PubMed ID: 11042216
[TBL] [Abstract][Full Text] [Related]
52. Role for the BRCA1 C-terminal repeats (BRCT) protein 53BP1 in maintaining genomic stability.
Morales JC; Xia Z; Lu T; Aldrich MB; Wang B; Rosales C; Kellems RE; Hittelman WN; Elledge SJ; Carpenter PB
J Biol Chem; 2003 Apr; 278(17):14971-7. PubMed ID: 12578828
[TBL] [Abstract][Full Text] [Related]
53. Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci.
Djuzenova CS; Elsner I; Katzer A; Worschech E; Distel LV; Flentje M; Polat B
Radiat Oncol; 2013 Apr; 8():98. PubMed ID: 23617930
[TBL] [Abstract][Full Text] [Related]
54. Characterization of a cancer cell line that expresses a splicing variant form of 53BP1: separation of checkpoint and repair functions in 53BP1.
Iwabuchi K; Matsui T; Hashimoto M; Matsumoto Y; Kurihara T; Date T
Biochem Biophys Res Commun; 2008 Nov; 376(3):509-13. PubMed ID: 18804090
[TBL] [Abstract][Full Text] [Related]
55. A prospective study on histone γ-H2AX and 53BP1 foci expression in rectal carcinoma patients: correlation with radiation therapy-induced outcome.
Djuzenova CS; Zimmermann M; Katzer A; Fiedler V; Distel LV; Gasser M; Waaga-Gasser AM; Flentje M; Polat B
BMC Cancer; 2015 Nov; 15():856. PubMed ID: 26541290
[TBL] [Abstract][Full Text] [Related]
56. Checkpoint signalling: focusing on 53BP1.
Abraham RT
Nat Cell Biol; 2002 Dec; 4(12):E277-9. PubMed ID: 12461529
[No Abstract] [Full Text] [Related]
57. The Tudor tandem of 53BP1: a new structural motif involved in DNA and RG-rich peptide binding.
Charier G; Couprie J; Alpha-Bazin B; Meyer V; Quéméneur E; Guérois R; Callebaut I; Gilquin B; Zinn-Justin S
Structure; 2004 Sep; 12(9):1551-62. PubMed ID: 15341721
[TBL] [Abstract][Full Text] [Related]
58. Tudor domains track down DNA breaks.
Stucki M; Jackson SP
Nat Cell Biol; 2004 Dec; 6(12):1150-2. PubMed ID: 15573092
[No Abstract] [Full Text] [Related]
59. 53BP1 loss suppresses the radiosensitizing effect of icotinib hydrochloride in colorectal cancer cells.
Huang A; Yao J; Liu T; Lin Z; Zhang S; Zhang T; Ma H
Int J Radiat Biol; 2018 Apr; 94(4):327-334. PubMed ID: 29388453
[TBL] [Abstract][Full Text] [Related]
60. Expression of DNA damage checkpoint 53BP1 is correlated with prognosis, cell proliferation and apoptosis in colorectal cancer.
Bi J; Huang A; Liu T; Zhang T; Ma H
Int J Clin Exp Pathol; 2015; 8(6):6070-82. PubMed ID: 26261485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
